Journals / Bakırköy Tıp Dergisi / 2018 / Cilt: 14 - Sayı: 1

Cognitive dysfunction in patients with chronic obstructive pulmonary disease

Kronik Obstrüktif Akciğer Hastalığı Olan Hastalarda Kognitif Fonksiyonların Değerlendirilmesi

Pages
109–114
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, we demonstrated a relationship between TAC and cognitive dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic obstructive pulmonary disease (COPD) is characterized with air flow limitation.
📊
Key Findings & Data:Methods: Twenty-eight hypoxic (group 1), 28 non-hypoxic COPD patients (group 2) and 25 healthy people (control group, group 3) were included to study.
💡
Conclusion & Impact:In addition, we demonstrated a relationship between TAC and cognitive dysfunction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is characterized with air flow limitation. Cognitive problems can appear in advanced stage of COPD. There is relationship between COPD and levels of homocystein (hcy) and total antioxidant capacity (TAC). There is also relationship between cognitive dysfunction and levels of hcy and TAC. We aimed evaluation of cognitive functions in patients with COPD, and demonstration of the relationship between cognitive function and hcy and TAC. Methods: Twenty-eight hypoxic (group 1), 28 non-hypoxic COPD patients (group 2) and 25 healthy people (control group, group 3) were included to study. Hcy and TAC levels were measured in all subjects. Cognitive functions were evaluated in all subjects with standardized mini mental test (SMMT), clock drawing test (CDT), Blessed orientation memory concentration test (BOMCT), Benton’s facial recognition test (BFRT) and clinical dementia rating scale (CDRS). Results: Hcy levels were high in group 1 (p=0.004), TAC levels were high in group 1 and 2 (p=0.04). SMMT (p=0.000) and CDT values were low in group1 (p=0.000), CDRS values were high in group1 and 2 (p=0.000), BFRT values were low in group1 and 2 (p=0.000), BOMCT values were high in group1 (p=0.000). There were a correlation between TAC and SMMT (r=0.582, p=0.001) and CDRS (r= -0.384, p=0.044). Conclusions: We demonstrated presence of cognitive dysfunction in COPD patients. Patients with hypoxic had more profound cognitive dysfunction. In addition, we demonstrated a relationship between TAC and cognitive dysfunction.

Özet

Amaç: Kronik obstrüktif akciğer hastalığı (KOAH) hava akımı kısıtlanmasıyla karakterize bir hastalık olup, hastalığın ileri aşamalarında kognitif problemler gelişebilmektedir. KOAH gelişimi ile homosistein düzeyleri ve total antioksidan kapasite (TAK) arasındaki ilişki, kognitif bozukluk ile homosistein düzeyleri ve TAK arasındaki ilişki bilinmektedir. Çalışmamızda KOAH’lı hastalarda kognitif fonskiyonların değerlendirilmesi ve kognitif fonksiyonlarla homosistein ve TAK arasındaki ilişkinin gösterilmesi amaçlanmıştır. Yöntemler: Çalışmaya akut atağı olan 28 (grup 1), stabil durumda olan 28 (grup 2) KOAH’lı olgu alındı. 25 sigara içmeyen sağlıklı olgu ile kontrol grubu (grup 3) kuruldu. Hasta ve kontrol grubunda homosistein, TAK düzeylerine bakıldı. Standardize mini mental test (SMMT), saat çizme testi (SÇT), Blessed oryantasyon bellek konsantrasyon testi (BOBKT), Benton yüz tanıma testi (BYTT) ve klinik demans derecelendirme ölçeği (KDDÖ) ile kognitif fonksiyonlar değerlendirildi. Bulgular: Grup 1’de homosistein düzeyleri yüksek (p=0.004), grup 1 ve 2’de TAK düzeyleri yüksek (p=0.04), grup 1’de SMMT değerleri (p=0.000) ve SÇT değerleri (p=0.000) düşük, grup 1 ve 2’de KDDÖ değerleri yüksek (p=0.000), grup 1 ve 2’de BYTT değeri düşüktü (p=0.000). Grup 1’de TAK ile SMMT (r=0.582, p=0.001) ve KDDÖ (r=-0.384, p=0.044) arasında korelasyon saptandı. Sonuçlar: Çalışmamızda kronik obstrüktif akciğer hastalığı bulunan hastalarda kognitif bozukluğun varlığı gösterilmiş, bu bozukluğun hipoksik olanlarda daha belirgin olduğu ortaya konmuştur. Ayrıca çalışmamızda TAK ile kognitif bozukluk arasındaki ilişki gösterilmiştir

🔖

Cite This Article

PEKEL, N. B., TURGUT, N., ALTIAY, G., DEMİR, A. M., TURGUT, B., ERBAŞ, H., SÜT, N. (2018). Cognitive dysfunction in patients with chronic obstructive pulmonary disease. Bakırköy Tıp Dergisi, Cilt: 14 - Sayı: 1, 109–114. https://ajindex.com/articles/127527

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Perrig WJ, Perrig P, Stahelin HB. The relation between antioksidants and memory performance in the old and very old. J Am Geriatr Soc 1997;45:718-24. [CrossRef] Rodrigo R, Passalacqua W, Araya J, Orellna M, Rivera G. Implications of oxidative stres and homocysteine in the pathophysiology of essential hypertension, J Cardiovasc Pharmacol 2003;42:453-61.[CrossRef] Sano M, Ernesto C, Thomas RG. A controlled trial of selejine, alfa-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s disease cooperative study. N Engl J Med 1997;336;1216-22.
  2. Rensburg SJ, ZyL JM, Potocnik FVC. The effect of stres on the antioxidative potential of serum: implications for Alzheimer’s diasease. Metab Brain Dis 2006;21:171-9.
  3. He Z, Li B, Yu L, Liu Q, Zhong N, Ran P. Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells. Respiration 2008;75:202-9. [CrossRef] Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmanary disease. COPD 2004;1:255-77.[CrossRef] Kocyiğit A, Erel O, Gur S. Effects of tobacco smoking on plasma selenium, zinc, copper and iron concentrations and related antioxidative enzyme activities. Clinical Biochemistry 2001;34:629-33.
  4. Sadowska AM, Klebe B, Germonpré P, De Backer WA. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication. Steroids 2007;72:1-6.[CrossRef] Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476-94. [CrossRef] Hanta İ, Kocabaş A, Canacankatan N, Kuleci S, Seydanoğlu G. Oxidant-antioxidant balance in patients with COPD. Lung 2006;184: 51-5. [CrossRef] Pavol J, Darina P, Branislav S, Zuzana D, Ruzena T. Oxidative stres in patients with COPD and pumonary hypertension. Wien Klin Wochenschr 2007;119:428-34. [CrossRef] McCaddon A, Hud son P, Davies G, Hugues A, Williams JH. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-13. [CrossRef] Budge M, Johnston C, Hogervorst E. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000;903:407-10. [CrossRef] Suhara T, Keisuke F,Yasuda O. Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 2004;43:1208-13. [CrossRef] Kruman, Culmsee C, Chan SL. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis ad hypersensitivity to